Evidence map›Paper›PMID 29641951›Full record

ArticleJournal of oncology practice2018

Priorities in the Cardiovascular Care of Breast Cancer Survivors.

Bonnie Ky

Abstract readComment
In one paragraph

Article in Journal of oncology practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Bonnie KyPerelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

Funding

Multimarker Risk Prediction in Cancer Therapy CardiotoxicityR01HL118018 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KY, BONNIE · 2014 to 2018
$3.7M
The Role of Neuregulin in Human Cardiac Remodeling and Heart FailureK23HL095661 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KY, BONNIE · 2010 to 2014
$704k
Markers of Oxidative and Nitrosative Stress in Anthracycline Cardiotoxicity and Statin CardioprotectionR21HL141802 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KY, BONNIE · 2018 to 2019
$469k
NHLBI NIH HHS K23 HL095661NHLBI NIH HHS R01 HL118018NHLBI NIH HHS R21 HL141802
6 · The paper itself

Abstract

Breast cancer is the most common malignancy in women with more than 3 million breast cancer survivors in the United States alone. Survivors of breast cancer suffer from an increased burden of cardiovascular risk factors and disease. The focus of this review is to describe the epidemiology of cardiovascular disease in breast cancer survivors, including the cardiovascular concerns observed with common cancer therapies. Strategies to improve upon the early detection and treatment of cardiovascular disease, including clinical prediction algorithms, biomarkers, and imaging measures are also reviewed, and the use of cardioprotective therapies to mitigate risk are summarized. Finally, the need for evidence-based research to inform and improve upon the multidisciplinary care of this growing population is highlighted.

Indexed as

Breast NeoplasmsCancer SurvivorsCardiovascular DiseasesFemaleHumansSurvivorsUnited States

Identifiers

PMID29641951
PMCPMC6804837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.